Market open
Boundless Bio Inc./$BOLD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Boundless Bio Inc.
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
Ticker
$BOLD
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
64
ISIN
US10170A1007
Website
BOLD Metrics
BasicAdvanced
$33M
-
-$2.95
-
-
Price and volume
Market cap
$33M
52-week high
$2.02
52-week low
$1.06
Average daily volume
64K
Financial strength
Current ratio
22.146
Quick ratio
21.813
Long term debt to equity
35.37
Total debt to equity
35.561
Management effectiveness
Return on assets (TTM)
-29.89%
Return on equity (TTM)
-54.06%
Valuation
Price to book
0.24
Price to tangible book (TTM)
0.24
Price to free cash flow (TTM)
-0.534
Growth
Earnings per share change (TTM)
-93.14%
BOLD News
AllArticlesVideos
Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights
GlobeNewsWire·6 days ago
Boundless Bio to Participate in the Needham Virtual Healthcare Conference
GlobeNewsWire·1 month ago
Boundless Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Boundless Bio Inc. stock?
Boundless Bio Inc. (BOLD) has a market cap of $33M as of May 15, 2025.
What is the P/E ratio for Boundless Bio Inc. stock?
The price to earnings (P/E) ratio for Boundless Bio Inc. (BOLD) stock is 0 as of May 15, 2025.
Does Boundless Bio Inc. stock pay dividends?
No, Boundless Bio Inc. (BOLD) stock does not pay dividends to its shareholders as of May 15, 2025.
When is the next Boundless Bio Inc. dividend payment date?
Boundless Bio Inc. (BOLD) stock does not pay dividends to its shareholders.
What is the beta indicator for Boundless Bio Inc.?
Boundless Bio Inc. (BOLD) does not currently have a Beta indicator.